ROCKET PHARMACEUTICALS, INC.·4

Jun 20, 4:10 PM ET

Makker Gotham 4

4 · ROCKET PHARMACEUTICALS, INC. · Filed Jun 20, 2024

Insider Transaction Report

Form 4
Period: 2024-06-13
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-13+23,94423,944 total
    Exercise: $22.86Exp: 2034-06-13Common Stock (23,944 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-06-13$15.04/sh+2,660$40,0062,660 total
    Exercise: $22.86Exp: 2034-06-13Common Stock (2,660 underlying)
Footnotes (2)
  • [F1]This option represents a right to purchase a total of 23,944 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025.
  • [F2]This option represents a right to purchase a total of 2,660 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025. This option was issued to the Reporting Person in lieu of director retainer fees of $40,000.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4